Diabetes
Conference Coverage
Medications provide best risk-to-benefit ratio for weight loss, says expert
Surgery provides the most weight loss, but has the greatest risk, according to an endocrinology, diabetes, and metabolism professor.
Conference Coverage
Can an endoscopic procedure treat type 2 diabetes?
This process is thought to improve insulin sensitivity, in part, by altering gut hormones and nutritional sensing,
Feature
Tirzepatide scores win in second obesity trial, SURMOUNT-2
Tirzepatide (Mounjaro) met its primary endpoints, compared with placebo, in the SURMOUNT-2 trial, designed to test weight-loss efficacy, in top-...
News
FDA okays latest artificial pancreas, the MiniMed 780G
The updated automated insulin delivery system features so-called meal detection technology and 7-day wear for the insulin pump.
From the Journals
What are the healthiest drinks for patients with type 2 diabetes?
“It is reasonable to shift the focus to drinks that are most likely to have positive health impacts: coffee, tea, plain water, and low-fat milk...
Latest News
Medicare expands CGM coverage to more with type 2 diabetes
Coverage for continuous glucose monitoring devices is now extended to all beneficiaries who use insulin.
From the Journals
Intermittent fasting plus early eating may prevent type 2 diabetes
“The results of this study add to the growing body of evidence to indicate that meal timing and fasting advice extends the health benefits of a...
From the Journals
Use age, not weight, to screen for diabetes; assess over 35s
‘If we make decisions about diabetes testing based on weight, we will miss some people from racial and ethnic minority groups who are developing...
From the Journals
NSAID use in diabetes may worsen risk for first HF hospitalization
“Given the well-established relationship between the use of NSAIDs and increased HF, these findings are not unexpected because type 2 diabetes is...
Commentary
What happens when newer weight loss meds are stopped?
Although these drugs are very effective for weight loss and treating diabetes, there can be adverse effects.
Conference Coverage
Dapagliflozin’s HFpEF benefit tied to lower filling pressure